These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 17446133)

  • 1. Transjugular intrahepatic portosystemic shunt prior to cardiac surgery with cardiopulmonary bypass in patients with cirrhosis and portal hypertension.
    Semiz-Oysu A; Moustafa T; Cho KJ
    Heart Lung Circ; 2007 Dec; 16(6):465-8. PubMed ID: 17446133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
    Kim JJ; Dasika NL; Yu E; Fontana RJ
    J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
    François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
    Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
    J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation.
    Cosenza CA; Hoffman AL; Friedman ML; Sher LS; Lopez RR; Van Allen R; Brown DH; Fraiman MH; Arnaout W; Vierling J; Makowka L
    Am Surg; 1996 Oct; 62(10):835-9. PubMed ID: 8813166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results.
    Pozler O; Krajina A; Vanicek H; Hulek P; Zizka J; Michl A; Elias P
    Hepatogastroenterology; 2003; 50(52):1111-4. PubMed ID: 12845992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'Gerstmann's Syndrome' of transjugular intrahepatic portosystemic shunt: should it be the left or should it be the right.
    Wong F
    Liver Int; 2009 Sep; 29(8):1129-31. PubMed ID: 19689612
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transjugular intrahepatic portosystemic shunt before hepatic surgery in a patient with cirrhosis and portal hypertension: case report].
    Chalret Du Rieu M; Carrere N; Bureau C; Lagarde S; Otal P; Pradere B
    J Chir (Paris); 2009 Apr; 146(2):191-4. PubMed ID: 19535077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
    Haskal ZJ; Radhakrishnan J
    J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow.
    Iversen P; Keiding S; Mouridsen K; Ott P; Vilstrup H
    Clin Gastroenterol Hepatol; 2011 Nov; 9(11):1001-3. PubMed ID: 21806953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transjugular intrahepatic portosystemic shunt: indications, prevention and management of complications].
    Wu X; Cao J; Wu X
    Zhonghua Wai Ke Za Zhi; 1995 Dec; 33(12):762-4. PubMed ID: 8762560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report.
    Wróblewski T; Rowiński O; Ziarkiewicz-Wróblewska B; Górnicka B; Albrecht J; Jones EA; Krawczyk M
    Transplant Proc; 2006; 38(1):204-8. PubMed ID: 16504703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of transjugular intrahepatic portosystemic shunt and surgical portocaval H-shunt for the treatment of colorectal variceal bleeding.
    Uemoto S; Martin AJ; Fleming W; Habib NA
    Hepatogastroenterology; 1995; 42(5):557-60. PubMed ID: 8751215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experiences with the transjugular intrahepatic portocaval shunt (TIPS)].
    Hausegger KA; Klein GE; Flückiger F; Sternthal MH; Wilding R; Stauber R
    Rofo; 1993 Sep; 159(3):229-35. PubMed ID: 8374109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding.
    Monescillo A; Martínez-Lagares F; Ruiz-del-Arbol L; Sierra A; Guevara C; Jiménez E; Marrero JM; Buceta E; Sánchez J; Castellot A; Peñate M; Cruz A; Peña E
    Hepatology; 2004 Oct; 40(4):793-801. PubMed ID: 15382120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.
    Su AP; Cao SS; Le Tian B; Da Zhang Z; Hu WM; Zhang Y; Wang ZL; Babu SR; Hu T
    Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):53-9. PubMed ID: 22099870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.
    Lotterer E; Wengert A; Fleig WE
    Hepatology; 1999 Mar; 29(3):632-9. PubMed ID: 10051460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.